Long-Term Assets: The sum of all assets classified as non-current.
Assembly Biosciences, Inc. (ASMB) had Long-Term Assets of $3.31M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$9.63M |
|
$-10.20M |
|
-- |
|
$9.63M |
|
$20.72M |
|
$-11.09M |
|
$0.90M |
|
$-10.20M |
|
$-10.20M |
|
$-10.20M |
|
$-10.20M |
|
$-10.20M |
|
$-10.20M |
|
$-11.09M |
|
$-11.44M |
|
7.66M |
|
7.66M |
|
$-1.33 |
|
$-1.33 |
|
| Balance Sheet Financials | |
$77.47M |
|
$0.22M |
|
|
Long-Term Assets |
$3.31M |
$80.78M |
|
$47.29M |
|
-- |
|
$15.39M |
|
$62.68M |
|
$18.10M |
|
$18.10M |
|
$18.10M |
|
7.67M |
|
| Cash Flow Statement Financials | |
$-40.20M |
|
$23.58M |
|
$2.28M |
|
$38.34M |
|
$24.01M |
|
$-14.34M |
|
$1.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-115.24% |
|
-115.24% |
|
-- |
|
-105.94% |
|
-105.94% |
|
$-40.20M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-56.34% |
|
-56.34% |
|
-12.62% |
|
-56.34% |
|
$2.36 |
|
$-5.25 |
|
$-5.25 |
|